MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Anxiety"

  • MDS Virtual Congress 2020

    Weeding Through the Haze: A Survey on Cannabis Use Among People with Parkinson’s Disease

    M. Feeney, B. Kluger, A. Stoessl, D. Bega, S. Gilbert, A. Hosang, E. Ogren, K. Schroeder, C. Evers, J. Beck (New York, NY, USA)

    Objective: To identify themes in cannabis use among people with Parkinson’s disease to inform medical recommendations and the design of future clinical trials. Background: Parkinson’s…
  • MDS Virtual Congress 2020

    Video-to-Home Cognitive-Behavioral Therapy for Veterans with Depression and Parkinson’s Disease: A Randomized Controlled Trial

    R. Dobkin, S. Mann, K. Rodriguez, L. St. Hill, R. Miller, A. King, M. Gara, A. Interian (Piscataway, NJ, USA)

    Objective: For the nearly 100,000 veterans with Parkinson’s disease (PD) receiving Veterans Affairs (VA) health care, depression is prevalent, yet often undiagnosed or undertreated. This…
  • MDS Virtual Congress 2020

    Carers of People Living with Parkinson’s Disease, the 2019 European Realities

    H. Rossinot, P.M Martin, P. Odin, K.R Chaudhuri, C. Billoet, S. Lindwall (Nancy, France)

    Objective: PD as a chronic disease interferes with the life of non professional relatives caring for the patient (carers). The aim of this survey is…
  • MDS Virtual Congress 2020

    Fear of progression in Parkinson’s disease: Preliminary results of a pilot cross-sectional study

    A. Folkerts, J. Saliger, J. Nielsen, H. Karbe, M. Goosses, V. Vida, C. Trenkwalder, A. Kruse, H. Oelsner, G. Ebersbach, E. Kalbe (Cologne, Germany)

    Objective: To examine the prevalence of fear of progression (FoP) in Parkinson's disease (PD) patients, and to analyze which sociodemographic, clinical and neuropsychological factors are…
  • MDS Virtual Congress 2020

    Differential burden of comorbidities for Huntington’s Disease, Parkinson’s Disease and the general population for patients and care partners in the US

    A. Exuzides, J. Matos, B. Ricker, D. Bega (South San Francisco, CA, USA)

    Objective: Describe the comorbidity burden for patients (pt) and care partners (cp) of Huntington’s Disease (HD), Parkinson’s Disease (PD) and the general population (GP) Background:…
  • MDS Virtual Congress 2020

    Profiling Atypical Anxiety in Parkinson’s Disease

    E. Forbes, G. Byrne, J. O'Sullivan, J. Yang, N. Dissanayaka (St Lucia, Australia)

    Objective: We aimed to identify the demographic, psychiatric, clinical and cognitive characteristics associated with Anxiety not otherwise specified (NOS) in persons with Parkinson’s disease (PWP).…
  • MDS Virtual Congress 2020

    Motor and non-motor symptoms in Huntington’s disease patients in the Tomsk region, Russia

    M. Nikitina, V. Alifirova, K. Nurzhanova, N. Zhukova (Tomsk, Russian Federation)

    Objective: The aim is to evaluate features of NMS in PwHD of Tomsk region. Background: Patients with Huntington's disease(PwHD) can complain of other non-motor symptoms(NMS)…
  • MDS Virtual Congress 2020

    Psychiatric comorbidities in Young Onset Parkinson’s disease

    A. Patwardhan, P. Pal, N. Kamble, R. Yadav (Bangalore, India)

    Objective: The study aims at exploring psychiatric comorbities;namely;anxiety,depression and impulse control disorders(ICD) and their inter relationship in a large cohort of Young onset PD(YOPD)patients. Background:…
  • MDS Virtual Congress 2020

    Effectiveness of case management interventions in reducing common preventable complications associated with Parkinson’s Disease: A Systematic Review and Meta-analysis

    A. van Halteren, J. Janssen Daalen, J. Ypinga, B. Bloem, M. Meinders, M. Munneke, S. Darweesh (Nijmegen, Netherlands)

    Objective: We sought to systematically examine the effectiveness of case management interventions on common preventable complications associated with Parkinson’s Disease, both in people with Parkinson’s…
  • MDS Virtual Congress 2020

    Risk of Suicidal Ideation After Deep Brain Stimulation Surgery in Patients with Parkinson’s Disease

    A. Seritan, J. Parad, S. Wang, J. Ostrem, A.M Iosif (San Francisco, CA, USA)

    Objective: To explore the association of preoperative risk factors with postoperative suicidal ideation in patients with Parkinson’s disease (PD) who had deep brain stimulation (DBS)…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 19
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley